Adrenomedullin22-52 suppresses high-glucose-induced migration, proliferation, and tube formation of human retinal endothelial cells. 2014

Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
Department of Ophthalmology, the First Affiliated Hospital of Soochow University, Suzhou, China PR.

OBJECTIVE To investigate the roles of an adrenomedullin receptor antagonist (adrenomedullin(22-52)) on high-glucose-induced human retinal endothelial cell (HREC) in vitro cell biology. METHODS HRECs were cultured with different concentrations of glucose and adrenomedullin(22-52). The proliferation of HRECs was evaluated by a cell counting kit-8 assay. Cell migration was assessed by scratch wound assay, and cell sprouting was detected by tube formation assay. The mRNA levels of adrenomedullin (ADM), vascular endothelial growth factor (VEGF), ADAMTS-1, and TSP-1 were measured by reverse-transcription polymerase chain reaction (RT-PCR). The VEGF and phosphatidylinositol 3' kinase (PI3K) pathway protein expression levels were assessed by western blot analysis. RESULTS Compared with 5 mM normal glucose treatment, 30 mM glucose significantly promoted the migration of HRECs, which was attenuated by 1 μg/ml adrenomedullin(22-52). The proliferation of HRECs was also suppressed by 1 μg/ml adrenomedullin(22-52). Furthermore, compared with other groups, 5 μg/ml of adrenomedullin(22-52) was shown to suppress high-glucose-induced tube formation of HRECs. With adrenomedullin(22-52) treatment, the mRNA level of ADAMTS-1 was significantly increased. Moreover, western blot and RT-PCR analyses showed that HRECs treated with 30 mM glucose exhibited increased VEGF and PI3K pathway protein levels, while the expression levels were suppressed by 5 μg/ml of adrenomedullin(22-52). CONCLUSIONS Our study indicated that adrenomedullin(22-52) mediated the migration, proliferation and tube formation after HRECs were exposed to high levels of glucose, which may be related to its ability to affect the expression of VEGF through the PI3K pathway.

UI MeSH Term Description Entries
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D012160 Retina The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. Ora Serrata
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071097 ADAMTS1 Protein An ADAMTS protease that contains two disintegrin loops and three C-terminal thrombospondin (TS) motifs. It functions as an ANGIOGENESIS INHIBITOR as well as in normal tissue growth and fertility. A Disintegrin And Metalloproteinase with Thrombospondin Motifs 1 Protein,ADAMTS-1 Protein,ADAMTS1 Protease,ADAMTS 1 Protein

Related Publications

Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
December 2017, Molecular medicine reports,
Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
March 2013, Diabetes, obesity & metabolism,
Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
January 1991, Virchows Archiv. B, Cell pathology including molecular pathology,
Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
February 2018, BMC ophthalmology,
Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
July 2012, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
June 2021, Biomedical engineering online,
Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
April 2017, Journal of diabetes and its complications,
Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
November 2021, Experimental and therapeutic medicine,
Zhigang Chen, and Gaoqin Liu, and Yanhui Xiao, and Peirong Lu
January 2021, Diabetes, metabolic syndrome and obesity : targets and therapy,
Copied contents to your clipboard!